Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression

被引:146
作者
Nguyen, KL
Llano, M
Akari, H
Miyagi, E
Poeschla, EM
Strebel, K
Bour, S
机构
[1] NIAID, Mol Microbiol Lab, Viral Biochem Sect, NIH, Bethesda, MD 20892 USA
[2] Mayo Clin, Program Mol Med, Rochester, MN 55905 USA
[3] NIAID, Bioinformat Core, Mol Microbiol Lab, Bethesda, MD 20892 USA
关键词
HIV-1; vpu; codon optimization; mRNA;
D O I
10.1016/j.virol.2003.11.021
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Two HIV-1 accessory proteins, Vpu and Vif, are notoriously difficult to express autonomously in the absence of the viral Tat and Rev proteins. We examined whether the codon bias observed in the vpu and vif genes relative to highly expressed human genes contributes to the Rev dependence and low expression level outside the context of the viral genome. The entire vpu gene as well as the 5' half of the vif gene were codon optimized and the resulting open reading frames (ORFs) (vphu and hvif, respectively) were cloned in autonomous expression vectors under the transcriptional control of the CMV promoter. Codon optimization efficiently removed the expression block observed in the native genes and allowed high levels of Rev- and Tat-independent expression of Vpu and Vif Most of the higher protein levels detected are accounted for by enhanced steady-state levels of the mRNA encoding the optimized species. Nuclear run-on experiments show for the first time that codon optimization has no effect on the rate of transcriptional initiation or elongation of the vphu mRNA. Instead, optimization of the vpu gene was found to stabilize the vphu mRNA in the nucleus and enhance its export to the cytoplasm. This was achieved by allowing the optimized mRNA to use a new CRM1-independent nuclear export pathway. This work provides a better understanding of the molecular mechanisms underlying the process of codon optimization and introduces novel tools to study the biological functions of the Vpu and Vif proteins independently of other viral proteins. Published by Elsevier Inc.
引用
收藏
页码:163 / 175
页数:13
相关论文
共 41 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor κB-dependent expression of antiapoptotic factors [J].
Akari, H ;
Bour, S ;
Kao, S ;
Adachi, A ;
Strebel, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (09) :1299-1311
[3]   Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release [J].
Bour, S ;
Akari, H ;
Miyagi, E ;
Strebel, K .
VIROLOGY, 2003, 309 (01) :85-98
[4]   Human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses [J].
Bour, S ;
Strebel, K .
JOURNAL OF VIROLOGY, 1996, 70 (12) :8285-8300
[5]  
Bour S, 2000, Adv Pharmacol, V48, P75
[6]   The human immunodeficiency virus type 1 Vpu protein inhibits NF-κB activation by interfering with βTrCP-mediated degradation of IκB [J].
Bour, S ;
Perrin, C ;
Akari, H ;
Strebel, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) :15920-15928
[7]   The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: A Vpu-like factor? [J].
Bour, S ;
Schubert, U ;
Peden, K ;
Strebel, K .
JOURNAL OF VIROLOGY, 1996, 70 (02) :820-829
[8]   Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD Env particle release activity [J].
Bour, SP ;
Aberham, C ;
Perrin, C ;
Strebel, K .
JOURNAL OF VIROLOGY, 1999, 73 (01) :778-782
[9]   REGULATION BY HIV REV DEPENDS UPON RECOGNITION OF SPLICE SITES [J].
CHANG, DD ;
SHARP, PA .
CELL, 1989, 59 (05) :789-795
[10]   VPU PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENHANCES THE RELEASE OF CAPSIDS PRODUCED BY GAG GENE CONSTRUCTS OF WIDELY DIVERGENT RETROVIRUSES [J].
GOTTLINGER, HG ;
DORFMAN, T ;
COHEN, EA ;
HASELTINE, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) :7381-7385